Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

I-FABP Levels in Pediatric Celiac Patients in Transition From Active Disease to Remission

NCT03244254 is registered in ClinicalTrials.gov with Schneider Children's Medical Center, Israel as lead sponsor.

NCT NCT03244254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03244254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
I-FABP Levels in Pediatric Celiac Patients in Transition From Active Disease to Remission
Lead sponsor
Schneider Children's Medical Center, Israel
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2017
Completion date
August 31, 2020
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease in children